Plasma olanzapine in relation to prescribed dose and other factors: data from a therapeutic drug monitoring service, 1999-2009.

Plasma olanzapine in relation to prescribed dose and other factors: data from a therapeutic drug monitoring service, 1999-2009.

Item
http://www.wikidata.org/entity/Q33939024
Plasma amisulpride in relation to prescribed dose, clozapine augmentation, and other factors: data from a therapeutic drug monitoring service, 2002-2010.Meta-analysis: the effects of smoking on the disposition of two commonly used antipsychotic agents, olanzapine and clozapine.Simultaneous quantification of olanzapine and its metabolite N-desmethylolanzapine in human plasma by liquid chromatography tandem mass spectrometry for therapeutic drug monitoring.Antipsychotic therapeutic drug monitoring: psychiatrists' attitudes and factors predicting likely future use.Sex differences in plasma clozapine and norclozapine concentrations in clinical practice and in relation to body mass index and plasma glucose concentrations: a retrospective survey.Treatment resistant or resistant to treatment? Antipsychotic plasma levels in patients with poorly controlled psychotic symptomsSafety of olanzapine use in adolescents.Pharmacogenetics of olanzapine metabolism.Olanzapine and risperidone plasma concentration therapeutic drug monitoring: A feasibility study.A Pilot Study of the Usefulness of a Single Olanzapine Plasma Concentration as an Indicator of Early Drug Effect in a Small Sample of First-Episode Psychosis Patients.Olanzapine pamoate for the treatment of schizophrenia--a safety evaluation.The Impact of Sertraline Co-Administration on the Pharmacokinetics of Olanzapine: A Population Pharmacokinetic Analysis of the STOP-PD.Olanzapine long-acting injection: insights from an early case series in the UK.Effects of age and gender on the serum levels of clozapine, olanzapine, risperidone, and quetiapine.Influence of FMO1 and 3 polymorphisms on serum olanzapine and its N-oxide metabolite in psychiatric patients.Integrating rare genetic variants into pharmacogenetic drug response predictions.
P2860

Plasma olanzapine in relation to prescribed dose and other factors: data from a therapeutic drug monitoring service, 1999-2009.

Item
http://www.wikidata.org/entity/Q33939024
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Plasma olanzapine in relation ...... monitoring service, 1999-2009.
@ast
Plasma olanzapine in relation ...... monitoring service, 1999-2009.
@en
type
label
Plasma olanzapine in relation ...... monitoring service, 1999-2009.
@ast
Plasma olanzapine in relation ...... monitoring service, 1999-2009.
@en
prefLabel
Plasma olanzapine in relation ...... monitoring service, 1999-2009.
@ast
Plasma olanzapine in relation ...... monitoring service, 1999-2009.
@en
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P698
P356
P1433
P1476
Plasma olanzapine in relation ...... monitoring service, 1999-2009.
@en
P2093
P304
P31
P356
10.1097/JCP.0B013E318221B408
P407
P433
P478
P50
P577
P698